Toggle menu

ENCEPH UK

Start date:
March 2015
End date:
December 2015 (Close to recruitment)
Co-ordinated by:
Brain Infections UK, University of Liverpool
Main trial site:
http://www.encephuk.org/studies

To produce a predictive tool for HSV encephalitis based on the early clinical features, by comparing the clinical features of those with and without HSV encephalitis.

 

Aim

To produce a predictive tool for HSV encephalitis based on the early clinical features, by comparing the clinical features of those with and without HSV encephalitis.

Trial Design

A Prospective multi-centre cohort observational study.

Eligibility criteria (summary of )

Patients who present to the Emergency Department or Acute Medical Unit with suspected encephalitis

Chief Investigator

Professor Tom Solomon

Local PI

Dr Matt Reed

Research Team

EMERGE Research team in collaboration with the Acute Medical Unit (AMU), Critical Care and the Virology team at the RIE

Further information

For more information please refer to main trial website  

Local PI

Dr Matt Reed

Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine

Research Team

Polly Black

Senior Research Nurse

Julia Grahamslaw

Lead Research Nurse

More EMERGE Trials

Molecular and cellular analysis of intracranial tumours

Read more

BRAINED

Molecular and cellular analysis of intracranial tumours

Patients commonly present to the Emergency Department with epistaxsis (nose bleed). Standard first aid measures such as applying pressure can often stem bleeding however in more severe cases of epistaxsis further treatment is required.

Read more

NoPac

Novel Use of Tranexamic Acid to Reduce the Need for Nasal Packing

The study with PP100-01 in combination with NAC is designed to determine safety and tolerability of PP100-01 when co-administered with NAC as compared to the 12-hr NAC treatment regime for patients that come to the hospital after an overdose of paracetamol/acetaminophen.

Read more

The POP Trial

A Randomised Open Label Exploratory, Safety and Tolerability Study with PP100-01 in Patients Treated with the 12-hour Regimen of N-Acetylcysteine for Paracetamol/Acetaminophen Overdose